MAPT and Alzheimer disease: Treatment with GSK3 blockers including non-selective ones like lithium and more selective ones like tideglusib reduced tau phosphorylation, lowered Aβ levels, and improved memory in AD-transgenic mice (Kramer et al., 2012; Shri et al., 2023).